Certain medications influence the levels of cyclic AMP and cyclic GMP by inhibiting phosphodiesterase.
Different isoforms of phosphodiesterase exhibit distinct substrate specificities.
Dysregulation of phosphodiesterase activity has been implicated in various cardiovascular diseases.
Further research is needed to fully understand the role of phosphodiesterase in disease.
Genetic mutations affecting phosphodiesterase can lead to rare inherited disorders.
Inhibiting phosphodiesterase can lead to an increase in cyclic AMP levels within cells.
It is hypothesized that inhibiting phosphodiesterase could improve cognitive function in patients with dementia.
Phosphodiesterase activity assays were performed to determine the efficacy of the drug.
Phosphodiesterase activity is essential for maintaining proper cell signaling and function.
Phosphodiesterase activity is often measured using fluorescent substrates.
Phosphodiesterase activity was found to be altered in response to oxidative stress.
Phosphodiesterase degradation products were analyzed by mass spectrometry.
Phosphodiesterase enzyme kinetics were analyzed using specialized software.
Phosphodiesterase enzymes are critical for regulating intracellular signaling pathways.
Phosphodiesterase enzymes are essential for maintaining cellular homeostasis.
Phosphodiesterase enzymes are essential for regulating the duration and intensity of cellular signals.
Phosphodiesterase enzymes are involved in a wide range of physiological processes.
Phosphodiesterase enzymes are involved in the breakdown of cyclic nucleotides, like cAMP.
Phosphodiesterase enzymes are involved in the regulation of cell growth and differentiation.
Phosphodiesterase enzymes are involved in the regulation of mood and behavior.
Phosphodiesterase enzymes are involved in the regulation of pain perception.
Phosphodiesterase enzymes catalyze the hydrolysis of cyclic nucleotides, ending the signaling cascade.
Phosphodiesterase enzymes play a critical role in modulating cellular responses to hormones.
Phosphodiesterase enzymes play a critical role in regulating the inflammatory response.
Phosphodiesterase expression is altered in response to various stimuli.
Phosphodiesterase inhibition can enhance the effects of certain neurotransmitters.
Phosphodiesterase inhibitors are being investigated as potential treatments for Alzheimer's disease.
Phosphodiesterase inhibitors are metabolized differently depending on the individual's genetic makeup.
Phosphodiesterase inhibitors are sometimes used to treat pulmonary arterial hypertension.
Phosphodiesterase inhibitors can be used to treat benign prostatic hyperplasia.
Phosphodiesterase inhibitors can be used to treat certain types of anxiety disorders.
Phosphodiesterase inhibitors can be used to treat certain types of depression.
Phosphodiesterase inhibitors can be used to treat certain types of inflammatory bowel disease.
Phosphodiesterase inhibitors can be used to treat certain types of skin disorders.
Phosphodiesterase inhibitors can be used to treat erectile dysfunction by increasing blood flow.
Phosphodiesterase inhibitors can have different effects depending on the dose used.
Phosphodiesterase inhibitors can improve cognitive function by increasing cyclic AMP levels in the brain.
Phosphodiesterase inhibitors can improve exercise capacity in patients with heart failure.
Phosphodiesterase inhibitors can improve lung function in patients with chronic obstructive pulmonary disease.
Phosphodiesterase inhibitors can improve sleep quality in patients with insomnia.
Phosphodiesterase inhibitors have been shown to have anti-inflammatory effects in some studies.
Phosphodiesterase inhibitors showed promise in preclinical models of neurodegenerative disease.
Research suggests that specific phosphodiesterase isoforms are linked to the severity of asthma symptoms.
Scientists are studying the impact of various drugs on phosphodiesterase activity in cardiac cells.
Specific phosphodiesterase isoenzymes are expressed in different tissues throughout the body.
Targeting phosphodiesterase offers a potential therapeutic strategy for treating pulmonary hypertension.
The activation of phosphodiesterase enzymes plays a crucial role in smooth muscle contraction.
The concentration of cyclic GMP is significantly affected by the activity of phosphodiesterase.
The design of selective phosphodiesterase inhibitors requires careful consideration of enzyme structure.
The development of new phosphodiesterase inhibitors is an ongoing area of research.
The development of selective phosphodiesterase inhibitors presents a promising avenue for drug discovery.
The drug targets phosphodiesterase enzymes to improve blood flow to the lungs.
The drug works by selectively blocking the activity of a particular type of phosphodiesterase.
The effects of phosphodiesterase inhibition on downstream signaling pathways were investigated.
The effects of phosphodiesterase inhibitors on smooth muscle relaxation are well documented.
The experiment aimed to quantify the phosphodiesterase activity in different brain regions.
The experiment investigated the effects of phosphodiesterase inhibition on vascular tone.
The experiment involved measuring the catalytic activity of purified phosphodiesterase.
The expression of phosphodiesterase is tightly regulated by hormonal signals.
The interaction between phosphodiesterase and other signaling molecules was explored.
The mechanism of action involves the deactivation of cyclic nucleotides by phosphodiesterase.
The newly synthesized drug acts as a potent phosphodiesterase inhibitor.
The phosphodiesterase gene sequence was determined and compared to known variants.
The regulation of cyclic nucleotide levels relies heavily on the action of phosphodiesterase.
The regulation of phosphodiesterase expression is complex and involves multiple factors.
The research group focused on developing potent and selective phosphodiesterase inhibitors.
The research team found elevated phosphodiesterase levels in diseased tissue samples.
The research team is focused on identifying new phosphodiesterase targets for cancer therapy.
The research team is focused on identifying new phosphodiesterase targets for treating autoimmune diseases.
The research team is focused on identifying new targets for phosphodiesterase inhibition.
The research team is working to develop phosphodiesterase inhibitors that can cross the blood-brain barrier.
The researchers are investigating the role of phosphodiesterase in signal transduction pathways.
The researchers are studying the role of phosphodiesterase in regulating blood pressure.
The researchers are studying the role of phosphodiesterase in regulating insulin secretion.
The researchers discovered a novel compound that selectively inhibits phosphodiesterase-5.
The researchers examined the effect of different inhibitors on various phosphodiesterase isoforms.
The researchers investigated the potential of combining phosphodiesterase inhibitors with other drugs.
The role of phosphodiesterase in regulating synaptic plasticity was examined.
The scientists are investigating the potential of phosphodiesterase inhibitors for treating arthritis.
The scientists are investigating the potential of phosphodiesterase inhibitors for treating glaucoma.
The scientists are investigating the potential of phosphodiesterase inhibitors for treating heart failure.
The scientists are investigating the potential of phosphodiesterase inhibitors for treating multiple sclerosis.
The scientists are investigating the potential of phosphodiesterase inhibitors for treating psoriasis.
The scientists are investigating the role of phosphodiesterase in regulating appetite.
The scientists are investigating the role of phosphodiesterase in regulating immune cell function.
The scientists are trying to develop phosphodiesterase inhibitors with fewer side effects.
The scientists are trying to identify new phosphodiesterase inhibitors from natural sources.
The specific phosphodiesterase isoform targeted depends on the therapeutic goal.
The study aims to elucidate the role of phosphodiesterase in regulating cardiac function.
The study controlled for confounding factors that might influence phosphodiesterase levels.
The study evaluated the safety and efficacy of a new phosphodiesterase inhibitor in clinical trials.
The study examined the relationship between phosphodiesterase expression and inflammatory responses.
The study found that phosphodiesterase activity is significantly reduced in a particular cell type.
The study showed that phosphodiesterase activity is elevated in patients with a specific disease.
The study suggests that phosphodiesterase inhibition may protect against age-related cognitive decline.
The study suggests that phosphodiesterase inhibition may protect against kidney damage.
The study suggests that phosphodiesterase inhibition may protect against liver damage.
The study suggests that phosphodiesterase inhibition may protect against neuronal damage.
The subcellular localization of phosphodiesterase enzymes influences their function.
Understanding the structure and function of phosphodiesterase is crucial for designing effective drugs.